Wang Zhiguo 4
4 · Yew Bio-Pharm Group, Inc. · Filed Dec 13, 2012
Insider Transaction Report
Form 4
Wang Zhiguo
DirectorPresident & CEO
Transactions
- Award
Options to purchase Common Stock
2012-12-13+20,103,475→ 20,103,475 totalExercise: $0.22From: 2012-12-13Exp: 2017-12-13→ Common Stock (20,103,475 underlying)
Footnotes (1)
- [F1]Does not include options to purchase 2,488,737 shares of Common Stock held by Mr. Wang's spouse.